| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precision Biosciences Inc (DTIL) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. DTIL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 243.4K | $1.72M | - | |
| CFO | 125.9K | $891.3K | - | |
| Other | 121.9K | $863.2K | - | |
| Other | 56.5K | $399.7K | - | |
| Dir | 28.1K | $199.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Brown Melinda53 | Director | Buy | 1,839 | $4.75 | $8,735.25 | +25.5% | +0.9% | +44.4% | |
| Mar 25, 2025 | Germano Geno J62 | Director | Buy | 3,250 | $5.30 | $17,225.00 | +41.6% | -11.0% | +27.1% | |
| Mar 24, 2025 | Amoroso Michael70 | President And CEO | Sale+OE | 964 | $5.56 | $5,359.84 | -0.9% | -19.7% | +13.5% | |
| Mar 4, 2025 | Smith J. Jefferson69 | Chief Research Officer | Sale+OE | 154 | $4.91 | $756.14 | -0.2% | -1.0% | -6.2% | |
| Mar 4, 2025 | Scimeca Dario83 | General Counsel And Secretary | Sale+OE | 272 | $4.91 | $1,335.52 | -1.1% | -1.0% | -6.2% | |
| Jan 22, 2025 | Smith J. Jefferson69 | Chief Research Officer | Sale+OE | 10,287 | $4.79 | $49,274.73 | -10.5% | +7.0% | -14.5% | |
| Jan 22, 2025 | Scimeca Dario83 | General Counsel And Secretary | Sale+OE | 8,928 | $4.79 | $42,765.12 | -26.8% | +7.0% | -14.5% | |
| Jan 21, 2025 | Amoroso Michael70 | President And CEO | Sale+OE | 36,838 | $4.67 | $172,033.46 | -25.6% | +12.5% | -12.1% | |
| Dec 30, 2024 | Germano Geno J62 | Director | Buy | 3,605 | $4.49 | $16,186.45 | +85.8% | +12.0% | +3.8% | |
| Dec 27, 2024 | Kelly John Alexander | Chief Financial Officer | Buy | 2,113 | $4.75 | $10,036.75 | +5.5% | -2.4% | -9.0% |